Document is current
Any future updates will be listed below
-
Authors
Trad, Ghida
Lenglet, Timothée
Ledoux, Isabelle
Querin, Giorgia
Blancho, Sophie
Marchand-Pauvert, Véronique
Hogrel, Jean-Yves
Pradat, Pierre-François
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06199284 at ClinicalTrials.govDocuments that mention this clinical trial
Safety, feasibility and preliminary effects of Atalante exoskeleton-assisted gait training in amyotrophic lateral sclerosis: a prospective ABA pilot study
https://doi.org/10.1186/s12984-026-02046-y
Safety and efficacy of the Atalante exoskeleton in the rehabilitation of French patients with amyotrophic lateral sclerosis: a prospective, monocentric, open, uncontrolled, interventional protocol, EXALS
https://doi.org/10.1136/bmjopen-2025-109620
-
Funding
Funding for this research was provided by:
Association pour la Recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du Motoneurone
- License Information
-
More Information
Article History
Received: 26 January 2026
Accepted: 3 June 2026
First Online: 1 July 2026
Declarations
Ethics approval and consent to participate: The study was approved by the French ethics committee CPP (reference no. 23.02378.000201). All participants provided written informed consent prior to inclusion.
Consent for publication: Not applicable.
Competing interests: JYH is a co-inventor of the MyoAnkle dynamometer used in this study and reports no personal financial interest. All other authors declare no competing interests.
